Westfall is proud to announce its recent equipment upgrades enabling accelerated speed-to-market for its customers plus double digit revenue growth with new product launch programs in both the medical production and QTM (Quick-Turn Manufacturing) segments of its business.
Ansonia, Conn. (July 31st, 2017) — NPI/Medical has purchased three new injection molding machines and one new CMM for its medical device, life sciences and healthcare customers to enable accelerated product development and faster speed-to-market for their new product introductions. The equipment upgrades offer several advantages for NPI/Medical’s customers that require speed to market, closed loop machine capabilities, and stringent process monitoring which are vital for new product launches, said NPI/Medical CEO Randy Ahlm.
“The new machinery is a part of NPI/Medical’s ongoing continuous improvement measures to benefit our customers through state-of-the-art enhancements,” Ahlm said. These additions also support our engineering and new product introduction development efforts.”
NPI/Medical recently purchased and installed one 330 ton Milacron Roboshot, an all-electric machine to support expanded medical device programs and accommodate larger shot size programs, a 80 ton Milacron MV80 Shuttle press to enhance our insert molding business, a 40 ton Arburg All-Rounder 270A, all-electric with an integrated Servo driven sprue picker and a ZEISS CONTURA (CMM) VAST XT Gold Coordinate Measuring System with active scanning and multipoint sensor with dynamic RDS, for accurate part inspections for our in-house Quality Assurance lab.
The machinery upgrades, Ahlm said, are part of NPI/Medical’s ongoing equipment replacement plan to facilitate the current business growth. “Growth from our medical device and life sciences production segment was nearly 20%, while our QTM (Quick-Turn Manufacturing) business grew over 30% in the last 12 months. Our unique prototype to production capability is creating huge dividends for our customers who wish to seamlessly launch new programs faster and without the disruption of changing suppliers during each phase of the new product launch process.”